PSO(PSO)
PSO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $3.69B | $3.87B | $4.04B | $3.58B |
| Low | $3.68B | $3.84B | $4.01B | $3.55B |
| High | $3.71B | $3.90B | $4.08B | $3.61B |
| EBITDA Avg | $1.54B | $1.61B | $1.69B | $1.49B |
| Low | $1.53B | $1.60B | $1.67B | $1.48B |
| High | $1.55B | $1.63B | $1.70B | $1.51B |
| EBIT Avg | $930M | $974M | $1.02B | $902M |
| Low | $926M | $967M | $1.01B | $894M |
| High | $936M | $983M | $1.03B | $911M |
| Net Income Avg | $463M | $516M | $574M | $581M |
| Low | $392M | $431M | $568M | $574M |
| High | $483M | $551M | $582M | $588M |
| EPS Avg | $0.70 | $0.78 | $0.87 | $0.88 |
| Low | $0.59 | $0.65 | $0.86 | $0.87 |
| High | $0.73 | $0.83 | $0.88 | $0.89 |
| Analysts (Rev / EPS) | 7 / 3 | 7 / 3 | 4 / 1 | 3 / 1 |